Apixaban Cuts Stroke But Ups Bleeding in Subclinical AF
Further analyses from the ARTESIA study and the previous NOAH-AFNET 6 trial are needed to try to identify groups where the benefit may outweigh the risk, researchers say.
Medscape Medical News
source https://www.medscape.com/viewarticle/998379?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/998379?src=rss
Comments
Post a Comment